Partnerships 2016

Care for HIV-infected mothers and their infants in a rural district of Tanzania

The objectives of this partnership were to improve HIV testing coverage in the ANC settings by reaching over 6,000 pregnant women and increasing the HIV testing rate above 90% in the whole district. A futher objective was to improve retention in care of HIV‐infected mothers by reducing loss to follow‐up to below 20%. It also aimed at the establishment of an Early Infant Diagnosis of HIV circuit at district level to offer reliable and timely early infant diagnosis for 200‐230 HIV exposed infants yearly. This should lead to a platform to generate reliable information concerning maternal and infant HIV care in rural Tanzania, to inform policy makers in Tanzania, and to support national policies.
Read More

A partnership to tackle women and mothers with pregnancy related diabetes in Tanzania

This partnership between Solidarmed and Lugala Lutheran Hospital aimed at training nurses on pathophysiology of Gestational Diabetes Mellitus, prevention and treatment with dietary measures, pharmacological treatment with insulin as well as introducing a routine screening for Gestational Diabetes Mellitus in pregnant women at the Lugala Lutheran Hospital. It further had the introduction of a standard long-term algorithm for diagnosing and treatment including counselling-based on the above results as an objective.
Read More

Scale-up infrastructure, specifically for gynaecological and obstetrics care according to local Master Plan

Improve and expand routine viral load monitoring for people living with HIV in the Districts of Butha-Buthe and Mokhotlong at the Butha-Buthe government hospital Laboratory; establish sustainable HIV drug resistance testing for patients with treatment failure while taking antiretroviral therapy at Seboche St Charles Mission Hospital laboratory, Butha-Buthe District.
Read More

Surveillance of Transmitted HIV-1 Drug Resistance in Drug-Naive and Newly Diagnosed Patients

The partnership assessed the prevalence of transmitted HIV‐1 drug resistance (TDR) in the chosen study sites and identified the most prevalent types of drug resistance mutations. They also assessed the potential to scale up of the HIV‐1 genotypic drug resistance test in Cameroon. Finally, they identified the major transmission routes of HIV‐1 and HIV‐1 drug resistance mutations in the study sites.
Read More